Trade Summary

3 days ago, Afeyan Noubar, serving as Dir, 10% owner at Generate Biomedicines, Inc. (GENB), purchased 4,687,500 shares at $16.00 per share, for a total transaction value of $75,000,000.00. Following this transaction, Afeyan Noubar now holds 62,673,117 shares of GENB.

This purchase represents a 8.00% increase in Afeyan Noubar's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, March 2, 2026 and publicly disclosed via SEC Form 4 filing on Monday, March 2, 2026, meaning the disclosure happened on the same day as the trade.